293480 Stock Chart & Stats
₩8630.00
₩70.00(0.82%)
―
--
Day’s Range― - ―
52-Week Range₩8,170.00 - ₩12,390.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)29.63K
Market Cap
₩148.08B
Enterprise ValueN/A
Total Cash (Recent Filing)₩6.57B
Total Debt (Recent Filing)₩66.07B
Price to Earnings (P/E)10.4
Beta0.12
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)826.15
Shares Outstanding17,772,945
10 Day Avg. Volume35,848
30 Day Avg. Volume29,625
Financial Highlights & Ratios
PEG Ratio-0.38
Price to Book (P/B)0.64
Price to Sales (P/S)0.83
P/FCF Ratio-10.04
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)1,247
Revenue Forecast (FY)₩257.30B
293480 FAQ
What was Hana Pharm Co., Ltd.’s price range in the past 12 months?
Hana Pharm Co., Ltd. lowest stock price was ₩8170.00 and its highest was ₩12390.00 in the past 12 months.
What is Hana Pharm Co., Ltd.’s market cap?
Hana Pharm Co., Ltd.’s market cap is ₩148.08B.
When is Hana Pharm Co., Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Hana Pharm Co., Ltd.’s earnings last quarter?
Hana Pharm Co., Ltd. released its earnings results on May 15, 2026. The company reported ₩565.472 earnings per share for the quarter, beating the consensus estimate of N/A by ₩565.472.
Is Hana Pharm Co., Ltd. overvalued?
According to Wall Street analysts Hana Pharm Co., Ltd.’s price is currently Undervalued.
Does Hana Pharm Co., Ltd. pay dividends?
Hana Pharm Co., Ltd. does not currently pay dividends.
What is Hana Pharm Co., Ltd.’s EPS estimate?
Hana Pharm Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Hana Pharm Co., Ltd. have?
Hana Pharm Co., Ltd. has 17,772,945 shares outstanding.
What happened to Hana Pharm Co., Ltd.’s price movement after its last earnings report?
Hana Pharm Co., Ltd. reported an EPS of ₩565.472 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -4.555%.
Which hedge fund is a major shareholder of Hana Pharm Co., Ltd.?
Currently, no hedge funds are holding shares in KR:293480
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Hana Pharm Co., Ltd.
Hana Pharm Co., Ltd. is a pharmaceutical enterprise that manufactures and supplies a diverse range of medicinal goods to both domestic South Korean and international markets. Its comprehensive product line covers various therapeutic categories, such as anesthetics, potent narcotic pain relievers, anti-nausea agents, muscle relaxants, and treatments targeting the cardiovascular, endocrine, gastrointestinal, respiratory, and central nervous systems. Furthermore, the company offers antibiotics, dermatological preparations, urological medications, osteoporosis therapies, and medications for pain, fever, and inflammation. The firm was established in 1958 and has its corporate headquarters located in Seoul, South Korea.
Dong Wha Pharm Co., Ltd.
―
Samil Pharmaceutical Co., Ltd.
―
SAMSUNG PHARMACEUTICAL.CO.,Ltd.
―
Daewon Pharmaceutical Co., Ltd
―
Jeil Pharmaceutical Co. Ltd.
―